Rockefeller University Press partners with Cashmere on AI licensing

Rockefeller University Press and Cashmere have formed a partnership to make RUP’s peer-reviewed life sciences research available for AI inference use cases under controlled licensing terms. The deal gives RUP visibility into how its journals are used in AI applications and is part of a broader push to set rules for premium scientific content in the AI era. Why it matters: - The partnership gives AI developers access to trusted, peer-reviewed biomedical content that can support healthcare, drug discovery and other life sciences applications. - The arrangement is designed to let publishers monetize AI inference use while keeping control over how their content is licensed and reported. - RUP’s journals carry more than a century of combined peer-reviewed discovery, which makes them especially valuable in high-stakes scientific and clinical settings. What happened: - Rockefeller University Press and Cashmere entered a partnership to bring RUP’s life sciences and biomedicine research into AI-powered applications for inference use cases. - The agreement covers RUP’s journals, including Journal of Cell Biology, Journal of Experimental Medicine, Journal of General Physiology and Journal of Human Immunity. - The companies announced the deal June 12, 2026. - Cashmere will provide infrastructure that enables safe, controlled and transparently reported AI inference use of RUP content. The details: - RUP will make its catalog available to AI platforms within clearly defined licensing boundaries. - RUP will retain visibility into how its content is used, by whom and to what commercial effect. - Cashmere’s platform will provide detailed usage analytics and transparent revenue reporting. - The partnership is built around Cashmere’s infrastructure suite for protecting, managing and licensing premium content in the AI era. - RUP also publishes or co-owns Journal of Human Immunity and Life Science Alliance, and the company says those journals were established by the research community and continue to be guided by scientists. - Cashmere says its platform is built on proprietary OmniPub infrastructure and is backed by a $5 million seed round led by Reach Capital. - More information is available at RUP , Cashmere and Cashmere on LinkedIn . Between the lines: - The deal reflects a broader shift in scholarly publishing toward formal AI licensing frameworks rather than open-ended access. - Cashmere is positioning itself as a bridge between premium publishers and AI companies as the inference economy expands. - RUP is signaling that scientific publishers want AI access terms that protect author rights, preserve licensing control and show where value is created. What’s next: - RUP content is expected to flow into AI applications through Cashmere’s controlled licensing system. - The partners are likely to use usage data and revenue reporting to manage the relationship and measure commercial value. - The partnership could serve as a template for other scientific publishers weighing how to license content for AI use.